(Q38815838)

6 September 2017

An overview of treatment approaches for chronic pain management (English)

1 reference

6 September 2017

0 references

0 references

2

1 reference

6 September 2017

Nicholas Hylands-White

series ordinal

1

1 reference

PubMed ID

27107994

6 September 2017

Jon H Raphael

series ordinal

3

1 reference

6 September 2017

23 April 2016

1 reference

Rheumatology International

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

1

1 reference

6 September 2017

29-42

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-016-3481-8

6 September 2017

0 references

cites work

The need for a new medical model: a challenge for biomedicine

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Coxibs and heart disease: what we have learned and what else we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

The comparative safety of opioids for nonmalignant pain in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Opioid Therapy for Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

The use of opioids in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Decreased central mu-opioid receptor availability in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Chronic opioid use in fibromyalgia syndrome: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Methodological fundamentals for the development of the guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Formulations of fentanyl for the management of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Current knowledge of buprenorphine and its unique pharmacological profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

21 January 2018

Antidepressants and pain

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Antidepressant treatment of fibromyalgia. A meta-analysis and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Review of pharmacological therapies in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Injection therapy for subacute and chronic low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Efficacy of radiofrequency procedures for the treatment of spinal pain: a systematic review of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Effectiveness of repeated radiofrequency neurotomy for lumbar facet pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Pain mechanisms: a new theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Physiology of spinal cord stimulation: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: Results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Spinal cord stimulation in severe angina pectoris--a systematic review based on the Swedish Council on Technology assessment in health care report on long-standing pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

The Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Deep brain stimulation for the treatment of various chronic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Deep brain stimulation for pain relief: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Deep brain stimulation for chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

EFNS guidelines on neurostimulation therapy for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Long-term outcomes of deep brain stimulation for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Noninvasive transcranial brain stimulation and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Efficacy of transcranial direct current stimulation and repetitive transcranial magnetic stimulation for treating fibromyalgia syndrome: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

The pain inhibiting pain effect: an electrophysiological study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

A history of local electrical analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Randomized double-blind sham-controlled crossover study of short-term effect of percutaneous electrical nerve stimulation in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Treating arthritis with locally applied heat or cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Nonoperative treatment of low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

From the gate to the neuromatrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Role of psychology in pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Meta-analysis of psychological interventions for chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Acceptance and commitment therapy: model, processes and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

The psychological flexibility model: a basis for integration and progress in psychological approaches to chronic pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Psychological therapies for the management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3481-8

Behavioural treatment for chronic low-back pain

21 January 2018

1 reference

12 December 2020

A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica

1 reference

12 December 2020

Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review

1 reference

12 December 2020

WHO guidelines for the use of analgesics in cancer pain.

1 reference

12 December 2020

Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers

1 reference

12 December 2020

Vanilloid (Capsaicin) receptors and mechanisms

1 reference

12 December 2020

'Pain inhibits pain' mechanisms: Is pain modulation simply due to distraction?

1 reference

12 December 2020

Is the WHO analgesic ladder still valid? Twenty-four years of experience.

1 reference

12 December 2020

Systematic review of outpatient services for chronic pain control.

1 reference

12 December 2020

Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin.

1 reference

12 December 2020

Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer

1 reference

12 December 2020

Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris

1 reference

12 December 2020

Exercise therapy for treatment of non-specific low back pain

1 reference

12 December 2020

2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary

1 reference

12 December 2020

A systematic review of therapeutic facet joint interventions in chronic spinal pain.

1 reference

12 December 2020

Capsaicin 8% topical patch (Qutenza)--a review of the evidence

1 reference

12 December 2020

Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.

1 reference

12 December 2020

Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia

1 reference

12 December 2020

Management of fibromyalgia syndrome

1 reference

12 December 2020

Acceptance and Commitment Therapy, Relational Frame Theory, and the Third Wave of Behavioral and Cognitive Therapies - Republished Article

1 reference

12 December 2020

Thermotherapy for treatment of osteoarthritis

1 reference

12 December 2020

Historical methods of counter-irritation

1 reference

12 December 2020

Analysis of psychological characteristics impacting spinal cord stimulation treatment outcomes: a prospective assessment.

1 reference

12 December 2020

Topical lidocaine for neuropathic pain in adults

1 reference

12 December 2020

Treatment of recurrent tension headache: a meta-analytic review.

1 reference

12 December 2020

Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.

1 reference

12 December 2020

Therapeutic heat and cold

1 reference

12 December 2020

Selective cyclooxygenase-2 inhibition by nimesulide in man

1 reference

12 December 2020

A brief cognitive-behavioral intervention reduces hospital admissions in refractory angina patients

1 reference

12 December 2020

Effects of spinal cord stimulation on coronary blood flow velocity

1 reference

12 December 2020

10.1007/S00296-016-3481-8

Identifiers

DOI

1 reference

PubMed ID

27107994

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

27107994